NCT06276036View on ClinicalTrials.gov

Autoimmune Cytopenias as a Sign of Primary Immunodeficiency.

NAActive, not recruitingINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

July 23, 2019

Primary Completion Date

December 1, 2024

Study Completion Date

June 1, 2025

Conditions
Cytopenia
Interventions
OTHER

Identification of specific markers

Analysis of the immunological profile, Genetic analysis using next-generation sequencing (NGS) technology, Bioinformatic analysis, Functional studies.

Trial Locations (6)

33620

University of South Florida, Tampa

Unknown

Ghent University Hospital, Ghent

Clinica Pediatrica - Università di Catania, Catania

Meyer Children's Hospital IRCCS, Florence

IRCCS Istituto Giannina Gaslini, Genova

Azienda Ospedaliero Universitaria Pisana, Pisa

All Listed Sponsors
lead

Meyer Children's Hospital IRCCS

OTHER